137 related articles for article (PubMed ID: 25518400)
1. [Kawasaki disease and innate immunity].
Hara T
Nihon Rinsho; 2014 Sep; 72(9):1542-7. PubMed ID: 25518400
[TBL] [Abstract][Full Text] [Related]
2. Kawasaki disease: a matter of innate immunity.
Hara T; Nakashima Y; Sakai Y; Nishio H; Motomura Y; Yamasaki S
Clin Exp Immunol; 2016 Nov; 186(2):134-143. PubMed ID: 27342882
[TBL] [Abstract][Full Text] [Related]
3. Genetic susceptibility to Kawasaki disease: analysis of pattern recognition receptor genes.
Onoyama S; Ihara K; Yamaguchi Y; Ikeda K; Yamaguchi K; Yamamura K; Hoshina T; Mizuno Y; Hara T
Hum Immunol; 2012 Jun; 73(6):654-60. PubMed ID: 22507623
[TBL] [Abstract][Full Text] [Related]
4. Update on etio and immunopathogenesis of Kawasaki disease.
Takahashi K; Oharaseki T; Yokouchi Y
Curr Opin Rheumatol; 2014 Jan; 26(1):31-6. PubMed ID: 24247115
[TBL] [Abstract][Full Text] [Related]
5. Kawasaki disease-specific molecules in the sera are linked to microbe-associated molecular patterns in the biofilms.
Kusuda T; Nakashima Y; Murata K; Kanno S; Nishio H; Saito M; Tanaka T; Yamamura K; Sakai Y; Takada H; Miyamoto T; Mizuno Y; Ouchi K; Waki K; Hara T
PLoS One; 2014; 9(11):e113054. PubMed ID: 25411968
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a murine model with arteritis induced by Nod1 ligand, FK565: A comparative study with a CAWS-induced model.
Ohashi R; Fukazawa R; Watanabe M; Hashimoto K; Suzuki N; Nagi-Miura N; Ohno N; Shimizu A; Itoh Y
Mod Rheumatol; 2017 Nov; 27(6):1024-1030. PubMed ID: 28150515
[TBL] [Abstract][Full Text] [Related]
7. Clinical and immunologic aspects of Kawasaki disease.
Leung DY
Immunodefic Rev; 1989; 1(3):261-71. PubMed ID: 2698643
[TBL] [Abstract][Full Text] [Related]
8. Injury to allografts: innate immune pathways to acute and chronic rejection.
Land WG
Saudi J Kidney Dis Transpl; 2005; 16(4):520-39. PubMed ID: 18202507
[TBL] [Abstract][Full Text] [Related]
9. Unique activation status of peripheral blood mononuclear cells at acute phase of Kawasaki disease.
Ikeda K; Yamaguchi K; Tanaka T; Mizuno Y; Hijikata A; Ohara O; Takada H; Kusuhara K; Hara T
Clin Exp Immunol; 2010 May; 160(2):246-55. PubMed ID: 20015095
[TBL] [Abstract][Full Text] [Related]
10. Innate immune responses following Kawasaki disease and toxic shock syndrome.
Chen KYH; Messina N; Germano S; Bonnici R; Freyne B; Cheung M; Goldsmith G; Kollmann TR; Levin M; Burgner D; Curtis N
PLoS One; 2018; 13(2):e0191830. PubMed ID: 29447181
[TBL] [Abstract][Full Text] [Related]
11. Galectins in innate immunity: dual functions of host soluble beta-galactoside-binding lectins as damage-associated molecular patterns (DAMPs) and as receptors for pathogen-associated molecular patterns (PAMPs).
Sato S; St-Pierre C; Bhaumik P; Nieminen J
Immunol Rev; 2009 Jul; 230(1):172-87. PubMed ID: 19594636
[TBL] [Abstract][Full Text] [Related]
12. A framework for understanding Kawasaki disease pathogenesis.
Lo MS
Clin Immunol; 2020 May; 214():108385. PubMed ID: 32173601
[TBL] [Abstract][Full Text] [Related]
13. Are the innate and adaptive immune systems setting hypertension on fire?
Bomfim GF; Rodrigues FL; Carneiro FS
Pharmacol Res; 2017 Mar; 117():377-393. PubMed ID: 28093357
[TBL] [Abstract][Full Text] [Related]
14. Arterial immune protein expression demonstrates the complexity of immune responses in Kawasaki disease arteritis.
Cameron SA; White SM; Arrollo D; Shulman ST; Rowley AH
Clin Exp Immunol; 2017 Nov; 190(2):244-250. PubMed ID: 28707750
[TBL] [Abstract][Full Text] [Related]
15. Coupling pathogen recognition to innate immunity through glycan-dependent mechanisms.
Davicino RC; Eliçabe RJ; Di Genaro MS; Rabinovich GA
Int Immunopharmacol; 2011 Oct; 11(10):1457-63. PubMed ID: 21600310
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-1beta Inhibition Attenuates Vasculitis in a Mouse Model of Kawasaki Disease.
Hashimoto Y; Fukazawa R; Nagi-Miura N; Ohno N; Suzuki N; Katsube Y; Kamisago M; Akao M; Watanabe M; Hashimoto K; Tsuno K; Matsui R; Itoh Y
J Nippon Med Sch; 2019; 86(2):108-116. PubMed ID: 31130561
[TBL] [Abstract][Full Text] [Related]
17. Innate immunity in allergic disease.
Minnicozzi M; Sawyer RT; Fenton MJ
Immunol Rev; 2011 Jul; 242(1):106-27. PubMed ID: 21682741
[TBL] [Abstract][Full Text] [Related]
18. Innate immune response analysis in COVID-19 and kawasaki disease reveals MIS-C predictors.
Yang CA; Huang YL; Chiang BL
J Formos Med Assoc; 2022 Mar; 121(3):623-632. PubMed ID: 34193364
[TBL] [Abstract][Full Text] [Related]
19. CD40 ligand gene and Kawasaki disease.
Onouchi Y; Onoue S; Tamari M; Wakui K; Fukushima Y; Yashiro M; Nakamura Y; Yanagawa H; Kishi F; Ouchi K; Terai M; Hamamoto K; Kudo F; Aotsuka H; Sato Y; Nariai A; Kaburagi Y; Miura M; Saji T; Kawasaki T; Nakamura Y; Hata A
Eur J Hum Genet; 2004 Dec; 12(12):1062-8. PubMed ID: 15367912
[TBL] [Abstract][Full Text] [Related]
20. Involvement of mannose-binding lectin in the pathogenesis of Kawasaki disease-like murine vasculitis.
Nakamura A; Okigaki M; Miura N; Suzuki C; Ohno N; Kametani F; Hamaoka K
Clin Immunol; 2014 Jul; 153(1):64-72. PubMed ID: 24721319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
